Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Ryan Specialty (RYAN)

Ryan Specialty names Stephen Keogh and Brendan Mulshine co-presidents, effective October 9

Neutral Impact 4 of 5 leadership Written later

Ryan Specialty appointed Chief Operating Officer Stephen Keogh and Chief Revenue Officer Brendan Mulshine as Co-Presidents, succeeding Jeremiah Bickham, who stepped down as President and moved to a non-employee strategic advisor role through January 1, 2026. The change alters the company's senior leadership structure, and the filing does not state compensation changes for either executive.

Key points

  • Stephen P. Keogh, age 59, is Co-President and Chief Operating Officer, effective October 9, 2025; he has served as COO since May 2025.
  • Brendan M. Mulshine, age 59, is Co-President and Chief Revenue Officer; he has served as CRO since 2020 and with the company since 2012.
  • Jeremiah Bickham's transition was agreed October 2, 2025, effective October 8, 2025, and he will serve as a strategic advisor through January 1, 2026.
  • Compensation changes for Keogh and Mulshine have not been determined.

The filing

CompanyRyan Specialty (RYAN)
Form8-K, current report
Filed with the SECOct 8, 2025, 4:17 PM ET
Accession number0001849253-25-000008

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:07 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 08, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.